Navigation Links
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir

Minimal Weight Change Reported Unlike What Is Commonly Seen In Insulin Therapy

CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- Novo Nordisk today announced results of a new study that further demonstrated the safety and efficacy of insulin Levemir(R) (insulin detemir [rDNA origin] injection). Patients with type 2 diabetes were able to adjust their own dosage of Levemir(R) and achieve improvements in blood sugar, comparable to dosing adjusted by their primary care physician. This improvement in A1c levels was observed with minimal weight change and without increases in rates of hypoglycemia.(1) The data were presented at the 67th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois.

"The study is a testament to the safety of Levemir(R), as patients were able to adjust their basal insulin dose on their own and achieve the same level of glycemic control as when guided by their doctor, while reducing the risk of hypoglycemia," said Luigi Meneghini, MD, MBA, Associate Professor of Clinical Medicine and the Director of the Eleanor and Joseph Kosow Diabetes Treatment Center at the Diabetes Research Institute, Miami, FL. "Since having type 2 diabetes requires a great deal of self-management, these findings will help empower patients to work more closely as partners with their physician to take control of their insulin treatment. The potential of improved self- management is made possible by insulin analogs like Levemir(R), which provide effective basal insulin coverage, and, as shown in this study, the added benefit of minimal weight change."

The new data were obtained from the insulin detemir 303 Algorithm tested in a Randomized Clinical Trial: The US PREDICTIVE(TM) 303 Trial (Predictable Results and Experience in Diabetes through Intensification and Control to Target: An International Variability Evaluation), which included 5,604 patients. The data showed that patient sel
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Animal Health ... About Animal Health Animal health refers ... or treat animals to enhance their quality of ... of animal food. The Global Animal Health market ...
(Date:8/27/2014)... Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend by 9% to twelve cents per ... with the dividend payable on September 22, 2014 to ... September 8, 2014. About Kewaunee Scientific ... Corporation is a recognized global leader in the design, ...
(Date:8/27/2014)... , Aug. 27, 2014  UBM Medica US announces ... online community for medical imaging professionals, presents special reporting ... Medical Imaging Management,s 2014 Annual Meeting . ... , 11 Principles of Successful Labor ... to greater profitability. , Why Don,t Patients ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
... and INDIANAPOLIS, Ind., May 5 A new substudy from ... showed that patients who took prasugrel and had a reduced ... risk of cardiovascular death, heart attack or stroke compared with ... were published online in Circulation on May 4, ...
... Oramed Pharmaceuticals, Inc.,(OTC: ORMP) ( http://www.oramed.com ), a ... clinical trials will commence this week on 30 ... evaluate the safety,tolerability and efficacy of its oral ... (CRO) located in Johannesburg,South Africa, will oversee the ...
Cached Medicine Technology:New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 2New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 3New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 4New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 5Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule 2
(Date:8/27/2014)... last things a parent wants to deal with, but ... a week old. , Skin that turns yellow can ... and isn,t adequately eliminating the chemical bilirubin. But that ... left untreated can harm a baby. , University of ... that checks for jaundice in newborns and can deliver ...
(Date:8/27/2014)... last time you experienced worrisome medical symptoms, did ... health-care professional? If so, you,re not alone. Consumers ... peer support groups to gather anecdotal information and ... and trustworthy sources. New research to be presented ... studies the characteristics of consumers who use the ...
(Date:8/27/2014)... 2014 For nearly two decades, audiences ... beloved mantra singers Deva Premal & Miten with their ... of their latest album in May, their 2014 MANTRAS ... countries around the globe, including Russia, Ukraine, Israel, Australia, ... Europe. With a new album and a new five-piece ...
(Date:8/27/2014)... BESLER Consulting , a leading provider ... is pleased to announce that it has been named ... Companies. The list represents the most comprehensive look at ... , "It's been an exciting year for our company ... year's Inc. 5000 list,” said Jonathan Besler, BESLER’s President ...
(Date:8/27/2014)... Home Care Assistance of Scottsdale , a ... to announce the next installment in its renowned Healthy ... Suzanne Steinbaum, attending cardiologist and Director of Women’s Heart ... National Spokesperson for the American Heart Association’s Go Red ... surrounding women and heart disease, what heart disease is ...
Breaking Medicine News(10 mins):Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3Health News:Educated consumers more likely to use potentially unreliable online healthcare information 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3
... the most comprehensive analyses yet done of the ancient history ... is not only native to the New World, but it ... evolved through birds and monkeys. The findings, presented ... researchers from Oregon State University, are based on the study ...
... HealthDay Reporter , WEDNESDAY, Nov. 2 (HealthDay News) -- Obese ... going about it in the most healthy or effective ways, ... teens trying to drop the pounds don,t seem to ... of nearly 44,000 adolescents who participated in the Philadelphia ...
... of the population of Denmark. The figure has been on ... Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), University of ... "In our study of over 400 children we ... in their rectums and the risk of development of allergic ...
... Cancer cells maintain their life-style of extremely rapid growth and ... that alters the cells, ability to metabolize glucose a ... Krainer, Ph.D., and his team at Cold Spring Harbor Laboratory ... cells to regain the metabolism of normal cells, have discovered ...
... at Wayne State University,s Parent Health Lab in the ... that identifies women at risk for drug use by ... use itself. In phase I testing, this new screener ... at detecting recent drug use. The team of researchers ...
... combined with physical activity can help to improve some of ... The study, which is published online in the European ... can have on obese people with sleep apnoea, compared to ... syndrome (OSAS) causes frequent pauses of breathing to occur during ...
Cached Medicine News:Health News:Analysis reveals malaria, other diseases as ancient, adaptive and persistent foes 2Health News:Analysis reveals malaria, other diseases as ancient, adaptive and persistent foes 3Health News:Overweight Teens Don't Seem to Grasp Weight Loss Rules 2Health News:Overweight Teens Don't Seem to Grasp Weight Loss Rules 3Health News:Dirt prevents allergy 2Health News:Study reveals details of alternative splicing circuitry that promotes cancer's Warburg effect 2Health News:Wayne State creating computer-based drug intervention for at-risk post-partum women 2Health News:Mediterranean diet and exercise can reduce sleep apnea symptoms 2
... (Penicillin G) inhibits bacterial ... synthesis. Streptomycin belongs to ... inhibits bacterial growth by ... is used for prevention ...
...
Contains 10,000 units of penicillin (base), 10,000 g of streptomycin (base), and 25 g of amphotericin B/ml utilizing penicillin G (sodium salt), streptomycin sulfate, and amphotericin B as Fungizone ...
All BioWhittaker Cell Culture Reagent and Buffer products are manufactured in accordance with cGMP regulations and are cell culture tested to assure compatibility. , Typical Properties, Sterility : ...
Medicine Products: